We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

OMC:NYSEOmnicom Group Inc. Analysis

Data as of 2026-05-21 - not real-time

$71.88

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Omnicom Group (OMC) is trading at a deep discount – the market price of $71.88 is far below the DCF‑derived fair value of roughly $597, implying a potential upside of nearly 40% according to the provided upside/downside metric. Revenue surged 69.2% YoY to $6.24 bn in Q1 CY2026, and non‑GAAP EPS of $1.90 topped consensus, underscoring robust top‑line momentum. However, technical signals remain bearish: the price sits beneath the 20‑, 50‑ and 200‑day SMAs, RSI is at 37, and MACD shows a bearish crossover, while volume is trending downwards. The stock offers a generous 4.45% dividend yield with a modest 41% payout ratio, supported by strong free cash flow of $5.07 bn, suggesting dividend sustainability.
Given the combination of exceptional earnings growth, attractive yield, and massive valuation gap, the fundamentals are compelling, but the short‑term price action reflects market caution. Investors should weigh the upside potential against the current bearish technical backdrop and moderate volatility of 24% over the past 30 days.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Significant revenue growth and earnings beat
  • High dividend yield with sustainable payout
  • Deep valuation discount despite bearish technicals

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Continued strategic partnerships (e.g., Adobe AI initiative)
  • Strong free cash flow supporting dividend and reinvestment
  • Potential mean‑reversion of price toward valuation target

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Secular shift toward data‑driven marketing fueling future growth
  • Resilient business model across diversified global markets
  • Sustained dividend income enhancing total return

Key Metrics & Analysis

Financial Health

Revenue Growth69.20%
Profit Margin0.32%
P/E Ratio5.8
ROE2.02%
ROA4.47%
Debt/Equity110.57
P/B Ratio2.2
Op. Cash Flow$3.2B
Free Cash Flow$5.1B
Industry P/E17.1

Technical Analysis

TrendBearish
RSI37.6
Support$69.98
Resistance$78.50
MA 20$75.24
MA 50$76.03
MA 200$76.73
MACDBearish
VolumeDecreasing
Fear & Greed Index90.29

Valuation

Fair Value$597.37
Target Price$99.80
Upside/Downside38.84%
GradeUndervalued
TypeBlend
Dividend Yield4.45%

Risk Assessment

Beta0.50
Volatility24.13%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.